These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 28257846

  • 1. 25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p.
    Zhang L, Lv Y, Xian G, Lin Y.
    Biochem Biophys Res Commun; 2017 Apr 15; 485(4):736-741. PubMed ID: 28257846
    [Abstract] [Full Text] [Related]

  • 2. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 15; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 3. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
    Izawa N, Kurotaki D, Nomura S, Fujita T, Omata Y, Yasui T, Hirose J, Matsumoto T, Saito T, Kadono Y, Okada H, Miyamoto T, Tamura T, Aburatani H, Tanaka S.
    J Bone Miner Res; 2019 Jun 15; 34(6):1143-1154. PubMed ID: 30721543
    [Abstract] [Full Text] [Related]

  • 4. Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
    Jules J, Zhang P, Ashley JW, Wei S, Shi Z, Liu J, Michalek SM, Feng X.
    J Biol Chem; 2012 May 04; 287(19):15728-38. PubMed ID: 22416138
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-124 regulates osteoclast differentiation.
    Lee Y, Kim HJ, Park CK, Kim YG, Lee HJ, Kim JY, Kim HH.
    Bone; 2013 Oct 04; 56(2):383-9. PubMed ID: 23867221
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K.
    J Bone Miner Res; 2005 Apr 04; 20(4):653-62. PubMed ID: 15765185
    [Abstract] [Full Text] [Related]

  • 7. Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism.
    Son A, Kang N, Oh SY, Kim KW, Muallem S, Yang YM, Shin DM.
    J Endocrinol; 2019 Sep 04; 242(3):241-249. PubMed ID: 31319381
    [Abstract] [Full Text] [Related]

  • 8. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM, Lee JH, Lee GS, Noh EM, Song HK, Gu DR, Kim SC, Lee SH, Kwon KB, Lee YR.
    BMC Complement Altern Med; 2017 Mar 23; 17(1):164. PubMed ID: 28335757
    [Abstract] [Full Text] [Related]

  • 9. TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression.
    Tokunaga T, Mokuda S, Kohno H, Yukawa K, Kuranobu T, Oi K, Yoshida Y, Hirata S, Sugiyama E.
    Int J Mol Sci; 2020 Jan 25; 21(3):. PubMed ID: 31991837
    [Abstract] [Full Text] [Related]

  • 10. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.
    Biochem Pharmacol; 2013 Sep 15; 86(6):782-90. PubMed ID: 23928189
    [Abstract] [Full Text] [Related]

  • 11. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G, Wang FF, Li T, Jia DD, Shen Y, Xu HC.
    Med Sci Monit; 2018 Apr 26; 24():2569-2577. PubMed ID: 29698379
    [Abstract] [Full Text] [Related]

  • 12. Effects of pulsed electromagnetic fields on the expression of NFATc1 and CAII in mouse osteoclast-like cells.
    He J, Zhang Y, Chen J, Zheng S, Huang H, Dong X.
    Aging Clin Exp Res; 2015 Feb 26; 27(1):13-9. PubMed ID: 24869857
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-124 inhibits TNF-α- and IL-6-induced osteoclastogenesis.
    Ohnuma K, Kasagi S, Uto K, Noguchi Y, Nakamachi Y, Saegusa J, Kawano S.
    Rheumatol Int; 2019 Apr 26; 39(4):689-695. PubMed ID: 30547186
    [Abstract] [Full Text] [Related]

  • 14. Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.
    Yamashita T, Uehara S, Udagawa N, Li F, Kadota S, Esumi H, Kobayashi Y, Takahashi N.
    PLoS One; 2014 Apr 26; 9(1):e85878. PubMed ID: 24465763
    [Abstract] [Full Text] [Related]

  • 15. 27-Hydroxycholesterol enhanced osteoclastogenesis in lung adenocarcinoma microenvironment.
    Zhang L, Liu M, Liu J, Li X, Yang M, Su B, Lin Y.
    J Cell Physiol; 2019 Aug 26; 234(8):12692-12700. PubMed ID: 30511368
    [Abstract] [Full Text] [Related]

  • 16. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ, Ohk B, Yoon HJ, Kang WY, Seong SJ, Kim SY, Yoon YR.
    Cell Signal; 2017 Jan 26; 29():226-232. PubMed ID: 27836739
    [Abstract] [Full Text] [Related]

  • 17. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
    Fretz JA, Shevde NK, Singh S, Darnay BG, Pike JW.
    Mol Endocrinol; 2008 Mar 26; 22(3):737-50. PubMed ID: 18063694
    [Abstract] [Full Text] [Related]

  • 18. miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway.
    Dinesh P, Kalaiselvan S, Sujitha S, Rasool M.
    J Cell Physiol; 2020 Dec 26; 235(12):9497-9509. PubMed ID: 32372426
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N, Kondo Y, Odkhuu E, Ulziisaikhan J, Ukaji T, Yokochi T, Umezawa K.
    Immunol Lett; 2014 Sep 26; 161(1):31-7. PubMed ID: 24792671
    [Abstract] [Full Text] [Related]

  • 20. miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
    Mizoguchi F, Murakami Y, Saito T, Miyasaka N, Kohsaka H.
    Arthritis Res Ther; 2013 Sep 26; 15(5):R102. PubMed ID: 24004633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.